These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hormone therapy: treatment halt taking too long]. Krankenpfl J; 2003; 41(10-12):214. PubMed ID: 14746195 [No Abstract] [Full Text] [Related]
4. Hormone replacement therapy and cancer: an update. La Vecchia C; Franceschi S Eur J Cancer Prev; 2003 Feb; 12(1):3-4. PubMed ID: 12548104 [No Abstract] [Full Text] [Related]
5. Complexity of surveillance for cancer risk associated with in-vitro fertilisation. Rossing MA; Daling JR Lancet; 1999 Nov; 354(9190):1573-4. PubMed ID: 10560666 [No Abstract] [Full Text] [Related]
6. Ovarian cancer and oral contraceptives. Grant EC Lancet; 2008 May; 371(9625):1662. PubMed ID: 18486733 [No Abstract] [Full Text] [Related]
7. Ovarian cancer and HRT in the Million Women Study. Narod SA Lancet; 2007 May; 369(9574):1667-8. PubMed ID: 17512836 [No Abstract] [Full Text] [Related]
8. [Hormone replacement therapy: curse or blessing?]. Schmidt M; Fink D; Lang U; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400 [TBL] [Abstract][Full Text] [Related]
9. [Contraceptive pills and neoplasms of the breast, uterus and ovaries]. Haddad J AMB Rev Assoc Med Bras; 1969 Jan; 15(1):43-50. PubMed ID: 4896303 [No Abstract] [Full Text] [Related]
10. [Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology]. Hammerstein J; Bolt HM; Breckwoldt M; von Eickstedt KW; Elger W; Hoffmann B; Köbberling J; Knorr D; Nieschlag E; Nocke W Dtsch Med Wochenschr; 1987 May; 112(22):897-9. PubMed ID: 3034544 [No Abstract] [Full Text] [Related]
11. By the way, doctor... I don't know whether to start hormone-replacement therapy. I'm having a terrible time with hot flashes, but I'm worried about the risk for ovarian and breast cancer. What should I do? Lee TH Harv Health Lett; 2001 Jun; 26(8):8. PubMed ID: 11439435 [No Abstract] [Full Text] [Related]
12. Menopausal hormones and risk of ovarian cancer. Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062 [TBL] [Abstract][Full Text] [Related]
13. Routine management of the woman on HRT. O'Connor R Ir Med J; 1995; 88(5):174. PubMed ID: 8575909 [No Abstract] [Full Text] [Related]
14. Cancer and the use of estrogens. Gambrell RD Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032 [TBL] [Abstract][Full Text] [Related]
15. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Venn A; Watson L; Bruinsma F; Giles G; Healy D Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672 [TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer and menopausal hormone therapy: more data and new questions. Lacey JV Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2524-5. PubMed ID: 18086754 [No Abstract] [Full Text] [Related]
17. Oral contraceptives and cancer. Holck S; Ebeling K Arch Geschwulstforsch; 1986; 56(2):155-67. PubMed ID: 3518652 [TBL] [Abstract][Full Text] [Related]
19. Hormonal contraceptives and the risk of cancer. Holck S World Health Stat Q; 1987; 40(3):225-32. PubMed ID: 3687058 [No Abstract] [Full Text] [Related]